
University of Tennessee
Also known as: Brian Jerkins, MD | East Tennessee Children's Hospital | LaBonheur Children's Hospital | Le Bonheur Children's Hospital | LeBonheur Children's Hospital | LeBonheur Children's Hospital- Neuroscience Institute | Lebonheur Children's Medical Center | LeBonheur Children's Medical Center | Le Bonheur Children's Medical Center, Memphis, TN | OB/ GYN Department Professor and Chair | Semmes Murphey Clinic and University of Tennessee Health Sciences Center | The University of Tennesee | The University of Tennessee Health Science Center | The University of Tennessee Health Science Center, Department of Transplant | The University of Tennessee, Knoxville | The West Clinic | The West Clinic, PC | University of Tennessee | University of Tennessee, | University of Tennessee at Memphis | University of Tennessee at Memphis Department of Medicine | University of Tennessee Cancer Institute | University of Tennessee Cancer Institute at St. Francis Hospital - Park Avenue | University of Tennessee Chattanooga Department of Obstetrics and Gynecology | University of Tennessee College of Medicine Chattanooga | University of Tennessee College of Medicine Chattanooga/Erlanger Health System | University of Tennessee Graduate School of Medicine | University of Tennessee Health Science Center | University of Tennessee Health Science Center and St. Jude Childrens' Research Hospital | University of Tennessee Health Science Center, Memphis | University of Tennessee Health Science Center Memphis, TN, USA | University of Tennessee Health Sciences Center | University of Tennessee Knoxville | University of Tennessee-Knoxville | University of Tennessee, Knoxville | University of Tennessee Knoxville, Department of Nutrition | University of Tennessee Medical Center | UT College of Medicine MIGS Fellow & Faculty | UTHSC Graduate School of Medicine | Wilford Hall Medical Center; University of Tennessee Health Science Center | Zhenzhen Liu
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1976Last known activity
May 31, 2025
Timeline
1790s
- Jan 1, 1794
University of Tennessee— Founded
Drugs by trial phase (138 distinct, 123 trials)
Phase 4 (28 own, 0 via acquisition)
Phase 3 (24 own, 0 via acquisition)
Phase 2 (39 own, 0 via acquisition)
Phase 1 (22 own, 0 via acquisition)
Other trials (25 own, 0 via acquisition)
Indications
Studied for
- Abscess
- Acute Kidney Injury
- Acute Lung Injury
- Acute Pain
- Amyloidosis
- Anemia, Neonatal
- Anemia, Sickle Cell
- Angiofibroma
- Angiolipoma
- Angiomyolipoma
- Arthritis
- Arthritis, Rheumatoid
- Atherosclerosis
- Bacterial Infections
- Behavior, Addictive
- Birth Weight
- Body Weight
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Bronchiolitis
- Bronchopulmonary Dysplasia
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cardiovascular Diseases
- Cerebral Hemorrhage
- Cholangitis
- Cholangitis, Sclerosing
- Communicable Diseases
- Connective Tissue Diseases
- Coronary Disease
- Critical Illness
- Delirium
- Desmoplastic Small Round Cell Tumor
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Drug-Related Side Effects and Adverse Reactions
- Ductus Arteriosus, Patent
- Eclampsia
- Eosinophilic Esophagitis
- Epilepsy
- Esophagitis
- Fabry Disease
- Facies
- Fractures, Bone
- Fractures, Open
- Gastroesophageal Reflux
- Genital Neoplasms, Female
- Gram-Positive Bacterial Infections
- Head and Neck Neoplasms
- Heart Diseases
- HELLP Syndrome
- Hemolysis
- Hemorrhage
- Hypercholesterolemia
- Hyperinsulinism
- Hypertension
- Hypertension, Pulmonary
- Immunoglobulin Light-chain Amyloidosis
- Infections
- Inflammatory Bowel Diseases
- Insulin Resistance
- Intestinal Diseases
- Intracranial Hemorrhages
- Ischemia
- Lung Diseases
- Lung Injury
- Lung Neoplasms
- Lymphangioleiomyomatosis
- Melanoma
- Multiple Myeloma
- Myocardial Ischemia
- Neonatal Abstinence Syndrome
- Neoplasms
- Neoplasms, Plasma Cell
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Neuroectodermal Tumors, Primitive, Peripheral
- Obesity, Morbid
- Opioid-Related Disorders
- Osteoporosis
- Pancreatic Neoplasms
- Paresthesia
- Persistent Fetal Circulation Syndrome
- Pharyngitis
- Plasmacytoma
- Pneumonia
- Pneumonia, Aspiration
- Postoperative Pain
- Pre-Eclampsia
- Premature Birth
- Psoriasis
- Psychomotor Agitation
- Pulmonary Valve Insufficiency
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
Recent trials (50)
- NCT06907849Lead sponsorPhase 2May 31, 2025
- NCT06925152Sponsor investigatorPhase 4May 31, 2025
- NCT06925152Lead sponsorPhase 4May 31, 2025
- NCT06907849OfficialPhase 2May 31, 2025
- NCT06842771Sponsor investigatorPhase 4Mar 31, 2025
- NCT06842771Lead sponsorPhase 4Mar 31, 2025
- NCT06669650Lead sponsorPhase 4Sep 25, 2024
- NCT06669650Sponsor investigatorPhase 4Sep 25, 2024
- NCT06506565Lead sponsorPhase 4Jul 8, 2024
- NCT06433674Lead sponsorPhase 3Jun 1, 2024
- NCT05951816Overall official - principal investigatorPhase 1Jul 31, 2023
- NCT05951816Lead sponsorPhase 1Jul 31, 2023
- NCT05968846Lead sponsorPhase 2Dec 7, 2022
- NCT05465226Lead sponsorPhase 4Aug 31, 2022
- NCT05116345Lead sponsorPhase 4Nov 30, 2021
Details
- Founded
- Knoxville, TN, US Jan 1, 1794
- Last known activity
- May 31, 2025